Postoperative Care and Outcomes in Solid-Organ Transplant Patients Undergoing Lower Extremity Fracture Treatment

被引:1
|
作者
Chiou, Daniel [1 ]
Mooney, Bailey H. [2 ]
Shi, Brendan [1 ]
Upfill-Brown, Alexander [1 ]
Kallini, Jennifer [1 ]
Soohoo, Nelson [1 ]
Johnson, Eric E. [1 ]
机构
[1] Univ Calif Los Angles, Dept Orthopaed Surg, 1225 15th St, Santa Monica, CA 90404 USA
[2] Univ Calif Los Angeles Calif, David Geffen Sch Med, Los Angeles, CA USA
关键词
solid-organ transplant; fractures; immunosuppression; postoperative care; TOTAL JOINT ARTHROPLASTY; TOTAL HIP-ARTHROPLASTY; BONE-DISEASE; OSTEOPOROSIS; COMPLICATIONS; IMPACT; PREVALENCE; MORTALITY; INFECTION; THERAPY;
D O I
10.1097/BOT.0000000000002788
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
OBJECTIVES:To determine the postoperative outcomes in solid-organ transplant (SOT) patients undergoing operative treatment of lower extremity fractures.Design:Retrospective comparative study.Setting:Academic Level 1 trauma center.Patient Selection Criteria:Patients who underwent SOT and operative treatment of lower extremity fracture from 2013 to 2021 were identified, excluding pathologic fractures.Outcome Measures and Comparisons:Postoperative complications, length of stay, time to death, 90-day and 1-year readmission rates, readmission causes, discharge location, and immunosuppressive regiments.RESULTS:Sixty-one patients with an average age of 67 years (range 29-88) were included. The mortality rate was 37.7%. The average follow-up was 15.2 months (range of 2 weeks-10 years). The majority of patients (32.8%) had received a liver transplant, and femoral neck fractures constituted the largest fracture group. The average length of stay was 10 days, with the shortest being 1 day and the longest being 126 days (SD 18). The majority of patients (57.3%) were not discharged home. Only 2 suffered from a postoperative complication requiring another procedure: hardware removal and liner exchange for periprosthetic joint infection, respectively. There was a 27.9% 90-day readmission rate with 2 deaths within that period with the most common being altered mental status (29.4%), genitourinary infections (17.6%), repeat falls (11.8%), and low hemoglobin requiring transfusion (11.8%). The longest average time to death analyzed by transplant type was found among lung transplant patients (1076 days, 62.5% mortality), followed by liver transplant patients (949 days, 35.0% mortality), and then kidney transplant patients (834 days, 38.9% mortality). The shortest time to death was 71 days from index procedure.CONCLUSIONS:Family members of SOT patients undergoing operative treatment of lower extremity fractures should be made aware of the high risk for 90-day readmission postoperatively (27.9%) and overall mortality (12.5%). Providers should be aware of the need for multidisciplinary involvement for inpatient care, monitoring postoperative complications, and facilitating discharge planning.LEVEL OF EVIDENCE:Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
收藏
页码:e238 / e244
页数:7
相关论文
共 50 条
  • [1] Intertrochanteric fracture fixation in solid organ transplant patients: outcomes and survivorship
    VanWagner, Michael J.
    Porter, Steven B.
    Spaulding, Aaron C.
    Shi, Glenn G.
    Wilke, Benjamin K.
    Ledford, Cameron K.
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2022, 142 (10) : 2739 - 2745
  • [2] SEPSIS IN SOLID-ORGAN TRANSPLANT PATIENTS
    Bafi, Antonio Tonete
    Vieira Tomotani, Daniere Yurie
    Rezende de Freitas, Flavio Geraldo
    SHOCK, 2017, 47 (01): : 12 - 16
  • [3] Survivorship After Primary Total Hip Arthroplasty in Solid-Organ Transplant Patients
    Chalmers, Brian P.
    Ledford, Cameron K.
    Statz, Joseph M.
    Perry, Kevin I.
    Mabry, Tad M.
    Hanssen, Arlen D.
    Abdel, Matthew P.
    JOURNAL OF ARTHROPLASTY, 2016, 31 (11) : 2525 - 2529
  • [4] Statins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipients
    Hsu, J.
    Andes, D. R.
    Knasinski, V.
    Pirsch, J.
    Safdar, N.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2009, 28 (11) : 1343 - 1351
  • [5] A Review of the Prevalence of Illicit Substance Use in Solid-Organ Transplant Candidates and the Effects of Illicit Substance Use on Solid-Organ Transplant Treatment Outcomes
    Majumder, Pradipta
    Sarkar, Siddharth
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (07)
  • [6] Patients with psychotic disorders in solid-organ transplant
    Zimbrean, Paula
    Emre, Sukru
    PROGRESS IN TRANSPLANTATION, 2015, 25 (04) : 289 - 296
  • [7] Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis
    Kamar, Nassim
    Lhomme, Sebastien
    Abravanel, Florence
    Marion, Olivier
    Peron, Jean-Marie
    Alric, Laurent
    Izopet, Jacques
    VIRUSES-BASEL, 2016, 8 (08):
  • [8] Outcomes of Femoral Neck Fracture Treated With Hip Arthroplasty in Solid Organ Transplant Patients
    Ledford, Cameron K.
    VanWagner, Michael J.
    Spaulding, Aaron C.
    Spencer-Gardner, Luke S.
    Wilke, Benjamin K.
    Porter, Steven B.
    ARTHROPLASTY TODAY, 2021, 11 : 212 - 216
  • [9] Intertrochanteric fracture fixation in solid organ transplant patients: outcomes and survivorship
    Michael J. VanWagner
    Steven B. Porter
    Aaron C. Spaulding
    Glenn G. Shi
    Benjamin K. Wilke
    Cameron K. Ledford
    Archives of Orthopaedic and Trauma Surgery, 2022, 142 : 2739 - 2745
  • [10] Hepatitis E Virus and the Kidney in Solid-Organ Transplant Patients
    Kamar, Nassim
    Weclawiak, Hugo
    Guilbeau-Frugier, Celine
    Legrand-Abravanel, Florence
    Cointault, Olivier
    Ribes, David
    Esposito, Laure
    Cardeau-Desangles, Isabelle
    Guitard, Joelle
    Sallusto, Federico
    Muscari, Fabrice
    Peron, Jean Marie
    Alric, Laurent
    Izopet, Jacques
    Rostaing, Lionel
    TRANSPLANTATION, 2012, 93 (06) : 617 - 623